ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 828

Development of a Disease Damage Index in Systemic Sclerosis Using Consensus and Data Driven Methods

Nava Ferdowsi1, Molla Huq1, Jodie Burchell2, Sam Mancuso2, Tien Tay1,3, Wendy Stevens4, Candice Rabusa4, Marie Hudson5, Vijaya Sundararajan2, David Prior6, Susanna Proudman7, Murray Baron8 and Mandana Nikpour9,10, 1Rheumatology, The University of Melbourne at St Vincent’s Hospital, Melbourne, Australia, 2Medicine, The University of Melbourne at St Vincent’s Hospital, Melbourne, Australia, 341 Victoria Parade, Fitzroy, St Vincent's Hospital, Melbourne, Australia, 4Rheumatology, St. Vincent’s Hospital, Melbourne, Australia, 5Medicine, McGill University, Montreal, QC, Canada, 6Cardiology, St Vincent's Hospital, Melbourne, Australia, 7Rheumatology Unit, Royal Adelaide Hospital North Terrace, Adelaide, Australia, 8Rheumatology, McGill University, Jewish General Hospital, Montreal, QC, Canada, 9St Vincent's Hospital, Melbourne, Australia, 10Medicine, The University of Melbourne at St. Vincent’s Hospital, Melbourne, Australia

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Data analysis, Morbidity and mortality and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: As there is currently no existing index for
quantifying organ damage in systemic sclerosis (SSc),
we sought to develop a disease damage index in SSc (SSc-DI) for use in interventional and observational studies.

Methods: The SSc-DI
working group, together with patient partners and expert advisors from disciplines
other than rheumatology, has developed the initial SSc-DI
using the following steps: (1)
Definition
of the concept of damage in SSc using consensus
methods in survey form (Figure 1); (2)
Item generation and definition through
systematic literature review; (3) Item reduction using an online survey
distributed to over 300 SSc experts internationally, together with Rasch modelling. (5) Univariable and
multivariable regression modelling to (i) determine
the relationship between the reduced list of items and death and (ii) to weight
the items, using prospectively acquired data from the Australian Scleroderma
Cohort Study (ASCS).

Results: A total of 83 items from 7 domains (organ systems) were
included in the online survey. A total of 93 responses from SSc
experts representing Australasia, North America and Europe were analysed. 58/83
items were retained based on the Delphi survey responses (³60% experts deemed
item appropriate). A further 27 items were dropped after Rasch
modelling, leaving 31 items to be considered for inclusion in the SSc-DI. Eight of the 31 remaining items were not collected
in the ASCS and therefore were unable to be analysed in regression models. The
cohort data set consisted of 1,544 patients, with 172 deaths (11.4%). The univariable relationship with death was statistically
significant in 16 items. The final SSc DI with weighted
scores can be seen in Table 1. Four items, although dropped in the Rasch analysis, were included in the final index by the investigators
as they were felt to reflect damage and conferred a mortality risk. The model
demonstrated good discrimination and calibration power (area under ROC curve =
0.83 and Hosmer-Lemeshow p = 0.54)

Conclusion: The combined use of consensus and data driven methods has
resulted in a weighted 16-item Damage Index that predicts mortality. Further work
includes creation of a separate index reflective of morbidity and external
validation of these indices using prospective cohort data.

Figure 1: Consensus definition of “damage” in SSc

Table 1: Systemic Sclerosis Damage Index (SSc-DI)


Disclosure: N. Ferdowsi, None; M. Huq, None; J. Burchell, None; S. Mancuso, None; T. Tay, None; W. Stevens, None; C. Rabusa, None; M. Hudson, None; V. Sundararajan, None; D. Prior, None; S. Proudman, None; M. Baron, None; M. Nikpour, None.

To cite this abstract in AMA style:

Ferdowsi N, Huq M, Burchell J, Mancuso S, Tay T, Stevens W, Rabusa C, Hudson M, Sundararajan V, Prior D, Proudman S, Baron M, Nikpour M. Development of a Disease Damage Index in Systemic Sclerosis Using Consensus and Data Driven Methods [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/development-of-a-disease-damage-index-in-systemic-sclerosis-using-consensus-and-data-driven-methods/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-a-disease-damage-index-in-systemic-sclerosis-using-consensus-and-data-driven-methods/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology